Home: Western blot, lab technician looking at Flow cytometry results, happy kid on a bike.
Home \ News

Latest Hycult Biotech news

Vacature ELISA specialist

Vacature ELISA specialist (32/40 uur per week) Hycult Biotech is gespecialiseerd in de ontwikkeling en productie van immunologische assays, antistoffen en eiwitten binnen het innate immunology veld. Onze producten worden ontwikkeld in samenwerking met toonaangevende wetenschappers wereldwijd, worden mondiaal verkocht...

NHP cells seen from under microscope, lab technician performing on complement ELISA and happy lady looking at air balloons
Discover Cross-Reactive Complement ELISA for NHP Research

Bridging Human and NHP Complement Research. At Hycult Biotech, we understand the importance of testing therapeutic agents on non-human primates (NHP) samples in order to get approval to enter clinical phases. That is why we have committed to the following...

New Human Complement Pathway Assays

We are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to...

Navigating the pitfalls in complement analysis

Our colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not...

Events

Upcoming Events 2024 Hycult Biotech regularly participates in, organizes, and supports various congresses. We believe it is crucial to keep up-to-date of the latest advancements in life science and to engage with all stakeholders involved. These events provide us with...

NEW Human C3d ELISA

We are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which...

New antibodies for complement related diseases

Introducing a new blocking antibody targeting complement C5, now available for preclinical research! Complement C5 plays a crucial role in many disease processes, and this new antibody offers the option to mimic blocking of terminal complement pathway. But that's not...

Hycult Biotech has partnered with Bioz

With this enhanced partnership, Hycult Biotech is leveraging Bioz' innovative product-specific article recommendations to guide customers in selecting reliable experimentation techniques and products, ultimately saving time and resources. Customers can now access product use-cases on Hycult Biotech's website through Bioz...

Tools for complement C3 activation in mouse model

Hycult Biotech has developed a new ELISA kit (cat.# HK2002) for detection of intact mouse C3 and that does not react with C3 fragments. Together with our mouse C3b specific ELISA (cat.# HK216), you will be able to quantify specific...

Clinical validation of C1-INH complex assays

Clinical validation of C1-INH complex assays in: COVID-19 and MIS-C  Hycult Biotech has developed new ELISA kits to monitor early classical pathway activation (via C1s/C1-INH complex), or early lectin pathway activation (via MASP-1/C1-INH complex). The tools are useful to investigate...

Calprotectin: relevant in any sample type

Calprotectin is a heterocomplex of the S100A8 and S100A9 proteins that is contained within the cytosol of neutrophils. When neutrophil migration takes place during an inflammatory response, calprotectin is released at the site of inflammation where it has a regulating...

TLR antibodies & ligands

Humans as well as other vertebrates are often exposed to lipopolysaccharide (LPS), for instance via enterobacteria. LPS responses are mediated via Toll-like receptor 4 (TLR4). TLRs are conserved pattern recognition receptors which recognize and respond to molecules derived from bacterial,...

Contact us